Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Owens & Minor (OMI) and Warby Parker (WRBY)
Critical Insights From Owens & Minor Analyst Ratings: What You Need To Know
UBS Adjusts Owens & Minor Price Target to $27 From $26, Maintains Buy Rating
Owens & Minor Analyst Ratings
Maintaining Sell Rating on Owens & Minor: Navigating Short-Term Hurdles While Investing for Long-Term Growth
Owens & Minor Analyst Ratings
UBS Maintains Buy on Owens & Minor, Raises Price Target to $28
Owens & Minor Analyst Ratings
JP Morgan Maintains Underweight on Owens & Minor, Lowers Price Target to $19
Owens & Minor Analyst Ratings
Challenging Outlook and Underperformance Anticipated for Owens & Minor: A Sell Rating Recommendation
Baird Adjusts Owens & Minor's Price Target to $18 From $21, Maintains Neutral Rating
ResMed Upgraded at JPMorgan; Says GLP-1 Threat Overdone
J.P. Morgan Sticks to Its Sell Rating for Owens & Minor (OMI)
Credit Suisse Maintains Neutral on Owens & Minor, Raises Price Target to $19
Owens & Minor Analyst Ratings
Bank of America Securities Reaffirms Their Sell Rating on Owens & Minor (OMI)
Baird Adjusts Owens & Minor Price Target to $21 From $18, Maintains Neutral Rating
Baird Maintains Neutral on Owens & Minor, Raises Price Target to $21
Credit Suisse Sticks to Their Hold Rating for Owens & Minor (OMI)
No Data